Epidemiological Evidence of Post-COVID IBS At 12-month follow-up, patients with COVID-19 had significantly higher IBS rates compared with controls (3.2% vs 0.5%, p=0.045). Post-COVID-19 IBS Integrative Review Authors , Authors of a peer-reviewed integrative review on post-COVID-19 IBS Mounting evidence points to a significant relationship between SARS-CoV-2 infection and subsequent development of irritable bowel syndrome, with expanding research now quantifying this association across diverse patient populations
Recombinant hGH therapy is contraindicated in patients with untreated diabetes, a history of cancer, increased intracranial pressure, carpal tunnel syndrome, edema, sleep apnea, and pancreatitis
The team will study the effects of GLP-1 drugs on five disproportionately burdened populations: racially minoritized groups, individuals of low socioeconomic status, rural and non-metro populations, people living with disabilities, and sexual and gender minorities
GHK-Cu demonstrates greater stability than BPC-157, remaining potent at room temperature for extended periods
Ohanian is one of Williams' loudest supporters, and recently gushed about his wife on TODAY
